Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RDHL

Redhill Biopharma Ltd ADR

Jun 08 • 04:00PM ET

1.02

0.00 0.00 %

Healthcare • Drug Manufacturers - Specialty & Generic • Israel • Nano • NASD

Peers: BFRI INM AKAN APUS AYTU CPHI RMTI TXMD BGM SCYX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	11.09%	Shs Outstand	5.19M	Perf Week	2.00%
Market Cap	5.29M	Forward P/E	-	EPS next Y	-	Insider Trans	-96.47%	Shs Float	4.62M	Perf Month	0.99%
Enterprise Value	2.47M	PEG	-	EPS next Q	-	Inst Own	3.23%	Short Float	0.47%	Perf Quarter	10.38%
Income	-	P/S	-	EPS this Y	-	Inst Trans	1.68%	Short Ratio	0.34	Perf Half Y	-15.00%
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.02M	Perf YTD	-0.97%
Book/sh	-1.93	P/C	1.75	EPS next 5Y	-	ROE	-	52W High	3.31 -69.18%	Perf Year	-48.74%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	95.56% 86.32%	ROIC	-	52W Low	0.71 43.64%	Perf 3Y	-97.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-83.27% -66.14%	Gross Margin	-	Volatility	10.09% 7.70%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	94.66%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	0.42	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	57.33	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.56	EPS Q/Q	102.33%	SMA20	2.69%	Beta	4.91	Target Price	7.75
Payout	-	Debt/Eq	-	Sales Q/Q	-90.21%	SMA50	9.20%	Rel Volume	0.00	Prev Close	1.02
Employees	13	LT Debt/Eq	-	Earnings	Apr 27 BMO	SMA200	-14.25%	Avg Volume	64.34K	Price	1.02
IPO	Jan 07, 2013	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	0	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)